Free Trial

Abbott Laboratories (ABT) News Today

Abbott Laboratories logo
$113.42
-0.65 (-0.57%)
(As of 10/29/2024 ET)
Abbott Laboratories logo and sign near company office in Silicon Valley. Abbott Labs is an American health care company. - Sunnyvale, California, USA , 2022 — Stock Editorial Photography
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
The stocks on this list are the top three buy-and-hold stocks in healthcare, producing significant value for shareholders while leading their respective fields.
Abbott Laboratories stock logo
Avitas Wealth Management LLC Sells 6,217 Shares of Abbott Laboratories (NYSE:ABT)
Avitas Wealth Management LLC cut its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 22.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,048 shares of the healthcare product maker
Abbott Laboratories Q3 Earnings Transcript
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Trading Up 0.4% - Should You Buy?
Abbott Laboratories (NYSE:ABT) Trading 0.4% Higher - Time to Buy?
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Shares Purchased by MONECO Advisors LLC
MONECO Advisors LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 110.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 31,148 shares of the healthcare product maker's stock after buying an additional 16,325 shar
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Trading 0.2% Higher - Still a Buy?
Abbott Laboratories (NYSE:ABT) Trading Up 0.2% - Time to Buy?
Abbott Laboratories stock logo
TCI Wealth Advisors Inc. Decreases Stock Holdings in Abbott Laboratories (NYSE:ABT)
TCI Wealth Advisors Inc. cut its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 40.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,393 shares of the healthcare product maker's stock af
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Shares Sold by DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale cut its position in Abbott Laboratories (NYSE:ABT - Free Report) by 3.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,543,279 shares of the healthcare product maker'
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Shares Sold by Sageworth Trust Co
Sageworth Trust Co trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 18.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 51,848 shares of the healthcare product maker's stock after selling
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Shares Down 1.1% - Here's Why
Abbott Laboratories (NYSE:ABT) Trading Down 1.1% - Here's What Happened
Abbott Laboratories stock logo
Mediolanum International Funds Ltd Sells 25,977 Shares of Abbott Laboratories (NYSE:ABT)
Mediolanum International Funds Ltd lowered its position in Abbott Laboratories (NYSE:ABT - Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 179,802 shares of the healthcare product maker's stock after selling 25,9
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Trading Down 0.4% - Here's What Happened
Abbott Laboratories (NYSE:ABT) Stock Price Down 0.4% - Here's Why
Abbott Laboratories stock logo
Assenagon Asset Management S.A. Sells 123,584 Shares of Abbott Laboratories (NYSE:ABT)
Assenagon Asset Management S.A. reduced its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 5.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,277,606 shares of the healthcare product maker's stock after selling
Abbott Laboratories stock logo
Courier Capital LLC Has $3.90 Million Stake in Abbott Laboratories (NYSE:ABT)
Courier Capital LLC lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 51.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,245 shares of the healthcare product maker's stock af
William Blair Analysts Increase Earnings Estimates for ABT
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Trading Down 0.2% - What's Next?
Abbott Laboratories (NYSE:ABT) Trading Down 0.2% - Here's Why
Abbott Laboratories stock logo
Eastern Bank Purchases 48,300 Shares of Abbott Laboratories (NYSE:ABT)
Eastern Bank boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 151.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 80,161 shares of the healthcare product maker's stock after
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Trading Down 1.7% - Here's Why
Abbott Laboratories (NYSE:ABT) Shares Down 1.7% - Time to Sell?
Abbott Laboratories stock logo
Border to Coast Pensions Partnership Ltd Acquires 15,816 Shares of Abbott Laboratories (NYSE:ABT)
Border to Coast Pensions Partnership Ltd grew its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 4.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 370,739 shares of the healthcare product maker's stock after acq
Abbott Laboratories (NYSE:ABT) Price Target Raised to $117.00
Abbott Laboratories stock logo
William Blair Issues Optimistic Forecast for ABT Earnings
Abbott Laboratories (NYSE:ABT - Free Report) - Investment analysts at William Blair raised their Q3 2025 EPS estimates for Abbott Laboratories in a report issued on Thursday, October 17th. William Blair analyst M. Kaczor now forecasts that the healthcare product maker will post earnings per share
Abbott Laboratories stock logo
Vest Financial LLC Acquires 53,887 Shares of Abbott Laboratories (NYSE:ABT)
Vest Financial LLC increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 12.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 470,358 shares of the healthcare product maker's stock
Abbott Laboratories stock logo
Ferguson Wellman Capital Management Inc. Sells 262,042 Shares of Abbott Laboratories (NYSE:ABT)
Ferguson Wellman Capital Management Inc. lowered its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 55.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21
Citi Keeps Their Buy Rating on Abbott Laboratories (ABT)
Financial markets news icon
MarketBeat Week in Review – 10/14 - 10/18 (ABT)
Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election.
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Stock Price Up 0.6% After Analyst Upgrade
Abbott Laboratories (NYSE:ABT) Stock Price Up 0.6% After Analyst Upgrade
Abbott Laboratories stock logo
FY2024 Earnings Estimate for ABT Issued By William Blair
Abbott Laboratories (NYSE:ABT - Free Report) - Analysts at William Blair lifted their FY2024 earnings estimates for shares of Abbott Laboratories in a research note issued on Thursday, October 17th. William Blair analyst M. Kaczor now forecasts that the healthcare product maker will post earnings
Abbott Laboratories stock logo
Sumitomo Mitsui DS Asset Management Company Ltd Has $22.77 Million Stake in Abbott Laboratories (NYSE:ABT)
Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 5.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 199,683 shares of the healthcare product maker
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Shares Down 0.3% - Should You Sell?
Abbott Laboratories (NYSE:ABT) Trading Down 0.3% - Here's What Happened
Abbott Laboratories stock logo
Abbott Laboratories (NYSE:ABT) Price Target Raised to $138.00
Sanford C. Bernstein increased their target price on shares of Abbott Laboratories from $133.00 to $138.00 and gave the stock an "outperform" rating in a research report on Thursday.
Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.

This is treason (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

ABT Media Mentions By Week

ABT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABT
News Sentiment

0.71

0.67

Average
Medical
News Sentiment

ABT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABT Articles
This Week

22

17

ABT Articles
Average Week

Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:ABT) was last updated on 10/30/2024 by MarketBeat.com Staff
From Our Partners